欢迎来到天天文库
浏览记录
ID:53271359
大小:300.46 KB
页数:4页
时间:2020-04-17
《阿维A治疗寻常型银屑病的疗效及对血清VEGF、IL-6的影响.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、718GuangxiMedwaZJoltrnaZ,Jun.2014,Vo1.36,No.6阿维A治疗寻常型银屑病的疗效及对血清VEGF、IL一6的影响▲肖敏贺琪陶娟(华中科技大学同济医学院附属协和医院皮肤科,武汉市430022,E-mail:xuhonglai1973@163.COrn)【摘要】目的观察阿维A治疗中、重度寻常型银屑病的临床疗效及其对血清血管内皮生长因子(VEGF)、白细胞介素_l5(IL-6)水平的影响。方法32例银屑病患者口服阿维A治疗,疗程8周,治疗前后采用银屑病皮损面积和严重程度指数评分标准(PASI)进行疗效
2、评定;采用酶联免疫吸附试验(ELISA)测定患者治疗前后血清VEGF和IL45水平并与18例健康对照组比较。结果32例中、重度寻常型银屑病患者治疗8周后有效率为87.50%;治疗后血清VEGF、IL-6水平明显低于治疗前(P3、子;白介素_l5【中图分类号】R751.05【文献标识码】A【文章编号】0253—4304(2014)06—0718-04DoI:10.11675/j.issn.0253.4304.2014.06.07EfficacyofAcitretinonPatientswithPsoriasisVulgarisandItsE仃酏tonSerumVascularEndothelialGrowthFactor.Interleukin-6XIAOMin,HEQi,TAOJuan(DepartmentofDermatology,AffiliatedU4、nionHospital,TongfiMedicalCollege,HuazhongUniversityofScienceandTechnology,Wuhan430022,China)【Abstract】ObjectiveTostudythetherapeuticefectofacitretinonmoderateorseverepsoriasisvulgarisandeffectofacitretinonserumlevelsofvascularendothelialgrowthfactor(~EGF),interleukin(5、IL)-6.MethodsThirty—twopatientswithpsoriasisvulgarisweretreatedwithoralacitretin,andthetreatmentlastedfor8weeks.TheeficacyoftreatmentwasevaluatedbyPsoriasisAreaandSeverityIndex(PASI)scores.ThelevelsofVEGFandILg5inserumofpatientsweredetectedbyenzyme—linkedimmunosorbenta6、ssay(ELISA),andwerecomparedwiththehealthycontrols(18cases).ResultsTheeffectiveratewasupto87.50%in32casesofmoderateorseverepsoriasisvulgarisafter8-weektreatment.TheserumlevelsofVEGFandIL-6aftertreatmentweresignificantlylowerthanthosebeforetreatment(P<0.O1).Theserumlevel7、sofVEGFandIL-6correlatedwithPASIscorespositivelyinpsoriasispatients(P<0.01).TheserumlevelsofVEGFandIL-6ofpsoriasispatientsweresignificantlyhigherthanthoseofcontrolgroupbeforeandaftertreatment(P<0.O1).ConclusionAcitretinhasbetterefectonthetreatmentofmoderateorseverepsor8、iasisvulgarisbyinhibitingtheserumlevelsofIL-6andVEGF.【Keywords】Psoriasis;Acitretin;Vascularendothelialgrowthfactor;In
3、子;白介素_l5【中图分类号】R751.05【文献标识码】A【文章编号】0253—4304(2014)06—0718-04DoI:10.11675/j.issn.0253.4304.2014.06.07EfficacyofAcitretinonPatientswithPsoriasisVulgarisandItsE仃酏tonSerumVascularEndothelialGrowthFactor.Interleukin-6XIAOMin,HEQi,TAOJuan(DepartmentofDermatology,AffiliatedU
4、nionHospital,TongfiMedicalCollege,HuazhongUniversityofScienceandTechnology,Wuhan430022,China)【Abstract】ObjectiveTostudythetherapeuticefectofacitretinonmoderateorseverepsoriasisvulgarisandeffectofacitretinonserumlevelsofvascularendothelialgrowthfactor(~EGF),interleukin(
5、IL)-6.MethodsThirty—twopatientswithpsoriasisvulgarisweretreatedwithoralacitretin,andthetreatmentlastedfor8weeks.TheeficacyoftreatmentwasevaluatedbyPsoriasisAreaandSeverityIndex(PASI)scores.ThelevelsofVEGFandILg5inserumofpatientsweredetectedbyenzyme—linkedimmunosorbenta
6、ssay(ELISA),andwerecomparedwiththehealthycontrols(18cases).ResultsTheeffectiveratewasupto87.50%in32casesofmoderateorseverepsoriasisvulgarisafter8-weektreatment.TheserumlevelsofVEGFandIL-6aftertreatmentweresignificantlylowerthanthosebeforetreatment(P<0.O1).Theserumlevel
7、sofVEGFandIL-6correlatedwithPASIscorespositivelyinpsoriasispatients(P<0.01).TheserumlevelsofVEGFandIL-6ofpsoriasispatientsweresignificantlyhigherthanthoseofcontrolgroupbeforeandaftertreatment(P<0.O1).ConclusionAcitretinhasbetterefectonthetreatmentofmoderateorseverepsor
8、iasisvulgarisbyinhibitingtheserumlevelsofIL-6andVEGF.【Keywords】Psoriasis;Acitretin;Vascularendothelialgrowthfactor;In
此文档下载收益归作者所有